Table 1.
Baseline Characteristics of Randomized Subjects
| CSII | MDI | |
|---|---|---|
| Number of patients | 168 | 163 |
| Age (years) | 55.5±9.7 | 56.4±9.5 |
| Gender (men/women) | 94/74 (56.0%/44.0%) | 86/77 (52.8%/47.2%) |
| Duration of diabetes (years) | 14.9±8.0 | 15.3±8.0 |
| Body mass index (kg/m2) | 33.5±7.5 | 33.2±7.0 |
| HbA1c [% (mmol/mol)] | 9.0±0.8 (75±8.7) | 9.0±0.8 (75±8.7) |
| Total daily insulin dose (units/day) | ||
| Long-acting | 57.4±30.3 | 52.4±27.7 |
| Rapid-acting | 55.6±31.7 | 53.8±30.8 |
| Insulin dose (units/kg/day) | 1.1±0.4 | 1.1±0.4 |
| Metformin use | 120 (71%) | 112 (69%) |
| Metformin dose (mg) | 1,810±680 | 1,788±636 |
Data are presented as mean±SD values or as number (percentage), as indicated.
CSII, continuous subcutaneous insulin infusion; HbA1c, glycated hemoglobin; MDI, multiple daily injections.